GT Biopharma (OXIA.MU) Q3 2026 Earnings

12AugConfirmed
Q2 2026
Next
-0.09
-0.09
-0.08
-0.07

Details

Expected EPS
-0.069136
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%

Description

GT Biopharma (OXIA.MU) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts